Clinical Trial Update: IMGN901 in Combination With Lenalidomide and Dexamethasone [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating IMGN901 in combination with lenalidomide and dexamethasone for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• IMGN901 (lorvotuzumab mertansine)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: ImmunoGen, Inc. | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED